- Lc laboratories|阿西替尼, 游离碱
- 重磅!珀金埃尔默3.83亿美元收购Horizon Discovery_资讯中心_
- 仪表网仪表展览网,仪器仪表交易信息门户行业网站、资讯平台!
- Development and characterization of a novel antiOX40 antibody fo...
- Discovery Antibodies_代理
- lifesensors 特约代理
- 生物医药的前沿进展与市场趋势,看各位大咖怎么谈
- 纪录片频道 腾讯视频 QQ
- 第十届抗体药物及新药研发高峰会总日程——EBC2020|药物|...
- HBV RNA检测技术盘点:RTqPCR VS RNA捕获探针法|rna|hbv|pcr_网易订阅
- 柯云路记录的《生命科学探索孙储琳1》
- PWR0 600 50R/J Metallux
Lyophilized Powder This product is freeze dried. All water molecules have been removed.
Antigen Incl. This antibody is shipped with its antigen FREE of charge!
- Peptide GKRFRKKSWEVYQG(C), corresponding to amino acid residues 336-349 of human B2R (Accession P30411). Intracellular, C-terminus.
-
Western blot analysis of rat brain lysate:1. Anti-B2 Bradykinin Receptor (BDKRB2) Antibody (#ABR-012), (1:1000).
2. Anti-B2 Bradykinin Receptor (BDKRB2) Antibody, preincubated with the control peptide antigen.
-
Expression of B2 bradykinin receptor in mouse spinal cordImmunohistochemical staining of mouse spinal cord using Anti-B2 Bradykinin Receptor (BDKRB2) Antibody (#ABR-012). A. BKR2 (red) appears in several spinal cord neurons (triangles). B. Parvalbumin (green) appears in neurons. C. Merge of BKR2 and parvalbumin shows co-expression in several neurons (triangles) but not all (arrow in C). DAPI is used as the counterstain.
- Rat trigeminal neuron primary cultures (Kawaguchi, A. et al. (2015) Front. Cell. Neurosci. 9, 229.).
- 1. Walker, K. et al (1995) Neurochem. Int. 26, 1.
- 2. Böckmann, S. and Paegelow, I. (2000) J. Leukoc. Biol. 68, 587.
- 3. Hess, J.F. et al. (2004) J. Pharmacol. Exp. Ther. 310, 488.
- 4. Souza, D.G. et al. (2004) J. Immunol. 172, 2542.
- 5. Calixto, J.B. et al. (2000) Pain 87, 1.
-
Kinins are small peptides produced rapidly following tissue injury that serve as important modulators of inflammation and pain. In the periphery, the actions of kinins include vasodilatation, increased vascular permeability, stimulation of immune cells, and induction of pain. Kinins in the central nervous system (CNS) seem to initiate a similar cascade of events leading to neural tissue damage, as well as long lasting disturbances affecting blood-brain barrier function.1
Kinins, such as Bradykinin (BK), Lys-BK, desArg9-BK, and Lys-desArg9-BK, exert their action via two distinct receptors: the B1 Bradykinin receptor (BKRB1) and the B2 Bradykinin receptor (BKRB2). BKRB2 is activated by BK and Lys-BK while desArg9-BK and Lys-desArg9-BK activate BKRB1.2 Activation of BKRB2 liberates mediators of vascular tone, fibrinolysis, and pain. BKRB2, which mediates most of the physiological effects of kinins, as well as BKRB1, represent potential therapeutic targets for treatment of inflammatory disorders and cardiovascular diseases.
Both BKRB1 and BKRB2 are members of the seven-transmembrane domain, G protein-coupled receptor (GPCR) superfamily and share a common structure of seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxy terminus.
BKRB2 is constitutively and widely expressed throughout the CNS and peripheral nervous system and on various cell types including endothelial cells, nerve fibers, leukocytes, and mast cells.3-5
Expression of B2 bradykinin receptor in rat TG neurons.Immunocytochemical staining of rat primary trigeminal ganglion (TG) neurons using Anti-B2 Bradykinin Receptor (BDKRB2) Antibody (#ABR-012). Adapted from Kawaguchi, A. et al. (2015) Front. Cell. Neurosci. 9, 229. with permission of Frontiers.
Anti-B2 Bradykinin Receptor (BDKRB2) Antibody (#ABR-012) is a highly specific antibody directed against an epitope of the human protein. The antibody can be used in western blot, immunohistochemistry, and immunocytochemistry applications. It has been designed to recognize B2R from human, rat, and mouse samples.
